Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Dyslipidemia

  Free Subscription


01.11.2021

1 Am J Cardiol
1 Am J Med
3 Atheroscler Suppl
6 Atherosclerosis
2 Circ Genom Precis Med
1 Endocrinol Metab Clin North Am
3 J Am Coll Cardiol
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cardiol

  1. KOBAYASHI N, Shibata Y, Kurihara O, Todoroki T, et al
    Impact of Low Body Mass Index on Features of Coronary Culprit Plaques and Outcomes in Patients With Acute Coronary Syndrome.
    Am J Cardiol. 2021 Aug 28. pii: S0002-9149(21)00728.
    PubMed         Abstract available


    Am J Med

  2. HOCH VL, Lin KH, Soffer D, Stone NJ, et al
    A "rule of thumb" aids evaluation of severe hypercholesterolemia to recognize familial hypercholesterolemia.
    Am J Med. 2021 May 25. pii: S0002-9343(21)00328.
    PubMed        


    Atheroscler Suppl

  3. GAZZOTTI M, Casula M, Olmastroni E, Averna M, et al
    How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia.
    Atheroscler Suppl. 2020;42:e35-e40.
    PubMed         Abstract available

  4. WATTS GF, Catapano AL, Masana L, Zambon A, et al
    Hypercholesterolemia and cardiovascular disease: Focus on high cardiovascular risk patients.
    Atheroscler Suppl. 2020;42:e30-e34.
    PubMed         Abstract available

  5. FOGER B, Jennings C, Pirillo A, Tokgozoglu L, et al
    Hypercholesterolemia and cardiovascular disease: What to do before initiating pharmacological therapy.
    Atheroscler Suppl. 2020;42:e25-e29.
    PubMed         Abstract available


    Atherosclerosis

  6. KOSUGI T, Eriguchi M, Yoshida H, Tasaki H, et al
    Association between chronic kidney disease and new-onset dyslipidemia: The Japan Specific Health Checkups (J-SHC) study.
    Atherosclerosis. 2021;332:24-32.
    PubMed         Abstract available

  7. KATZMANN JL, Lehmann M, Tunnemann-Tarr A, An Haack I, et al
    Cutaneous manifestations in familial hypercholesterolaemia.
    Atherosclerosis. 2021 Jul 11. pii: S0021-9150(21)01236.
    PubMed         Abstract available

  8. DYRBUS K, Gasior M, Desperak P, Trzeciak P, et al
    Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) registry.
    Atherosclerosis. 2021;333:16-23.
    PubMed         Abstract available

  9. AHMED AI, Han Y, Al Rifai M, Alnabelsi T, et al
    Added prognostic value of plaque burden to computed tomography angiography and myocardial perfusion imaging.
    Atherosclerosis. 2021;334:9-16.
    PubMed         Abstract available

  10. KLEVMOEN M, Bogsrud MP, Retterstol K, Svilaas T, et al
    Loss of statin treatment years during pregnancy and breastfeeding periods in women with familial hypercholesterolemia.
    Atherosclerosis. 2021;335:8-15.
    PubMed         Abstract available

  11. PAQUETTE M, Bernard S, Baass A
    Hemoglobin concentration, hematocrit and red blood cell count predict major adverse cardiovascular events in patients with familial hypercholesterolemia.
    Atherosclerosis. 2021;335:41-46.
    PubMed         Abstract available


    Circ Genom Precis Med

  12. LACAZE P, Sebra R, Riaz M, Hooper AJ, et al
    Familial Hypercholesterolemia in a Healthy Elderly Population.
    Circ Genom Precis Med. 2020 Jun 10. doi: 10.1161/CIRCGEN.120.002938.
    PubMed        

  13. TRINDER M, Paquette M, Cermakova L, Ban MR, et al
    Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia.
    Circ Genom Precis Med. 2020;13:515-523.
    PubMed         Abstract available


    Endocrinol Metab Clin North Am

  14. COONEY LG, Dokras A
    Cardiometabolic Risk in Polycystic Ovary Syndrome: Current Guidelines.
    Endocrinol Metab Clin North Am. 2021;50:83-95.
    PubMed         Abstract available


    J Am Coll Cardiol

  15. NURMOHAMED NS, Navar AM, Kastelein JJP
    New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4.
    J Am Coll Cardiol. 2021;77:1564-1575.
    PubMed         Abstract available

  16. TSIMIKAS S, Moriarty PM, Stroes ES
    Emerging RNA Therapeutics to Lower Blood Levels of Lp(a): JACC Focus Seminar 2/4.
    J Am Coll Cardiol. 2021;77:1576-1589.
    PubMed         Abstract available

  17. TALASAZ AH, Sadeghipour P, Aghakouchakzadeh M, Dreyfus I, et al
    Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:1635-1654.
    PubMed         Abstract available


    PLoS One

  18. GURM Z, Seth M, Daher E, Pielsticker E, et al
    Prevalence of coronary risk factors in contemporary practice among patients undergoing their first percutaneous coronary intervention: Implications for primary prevention.
    PLoS One. 2021;16:e0250801.
    PubMed         Abstract available

  19. ALHABIB KF, Al-Rasadi K, Almigbal TH, Batais MA, et al
    Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.
    PLoS One. 2021;16:e0251560.
    PubMed         Abstract available

  20. NIGUSSIE S, Birhan N, Amare F, Mengistu G, et al
    Rate of glycemic control and associated factors among type two diabetes mellitus patients in Ethiopia: A cross sectional study.
    PLoS One. 2021;16:e0251506.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: